Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 1/20 | 0.54 |
| ▸ | TSHR | P16473 | 4/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | APEX1 | P27695 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10940763 | 0.98 | THRB (0.53) | THRBTSHRALDH1A1POLBAPEX1 | |
| SCHEMBL6524977 | 0.87 | THRB (0.54) | THRBTSHRALDH1A1POLBAPEX1 | |
| Ethylene SCHEMBL8845054 | 0.86 | THRB (0.53) | THRBTSHRALDH1A1POLBAPEX1 | |
| Ethylene SCHEMBL6524832 | 0.86 | THRB (0.53) | THRBTSHRALDH1A1POLBAPEX1 | |
| SCHEMBL219932 | 0.86 | THRB (0.38) | THRBTSHRALDH1A1HTT | |
| SCHEMBL272813 | 0.86 | THRB (0.38) | THRBTSHRALDH1A1HTT | |
| Ethylene SCHEMBL8845041 | 0.86 | THRB (0.53) | THRBTSHRALDH1A1POLBAPEX1 | |
| Ethylene SCHEMBL11504618 | 0.86 | THRB (0.53) | THRBTSHRALDH1A1POLBAPEX1 | |
| SCHEMBL213461 | 0.85 | TSHR (0.38) | THRBTSHRALDH1A1 | |
| SCHEMBL8005857 | 0.84 | TSHR (0.57) | THRBTSHRALDH1A1POLBAPEX1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4571382-A | Process for determining tumor-associated glycolinkage and method for diagnosis of cancer | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1986-02-18 | — | — | US | claimed |
| US-20240209168-A1 | MONOMER COMPOSITION, MOLDED BODY, BONDED MAGNET, DUST CORE | RESONAC CORPORATION (JP) | 2024-06-27 | — | — | US | disclosed |
| WO-2022224309-A1 | MONOMER COMPOSITION, MOLDED BODY, BONDED MAGNET, DUST CORE | 昭和電工マテリアルズ株式会社 | 2022-10-27 | — | — | WO | disclosed |
| US-4571382-A | Process for determining tumor-associated glycolinkage and method for diagnosis of cancer | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1986-02-18 | — | — | US | disclosed |
| US-4552633-A | Fine particulate for use in clinical testing and a process for producing thereof | JAPAN ATOMIC ENERGY RESEARCH INSTITUTE (JP) | 1985-11-12 | — | — | US | disclosed |
| US-4455380-A | Process for determining tumor-associated glycolinkage | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1984-06-19 | — | — | US | disclosed |
| US-4177107-A | Process for producing composition containing insolubilized enzyme and/or insolubilized bacterial cells | JAPAN ATOMIC ENERGY RESEARCH INSTITUTE (JP) | 1979-12-04 | — | — | US | disclosed |